EPIPEN

This brand name is authorized in Austria, Australia, Canada, Estonia, Finland, France, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, United States, South Africa

Active ingredients

The drug EPIPEN contains one active pharmaceutical ingredient (API):

1 Adrenaline UNII YKH834O4BH - EPINEPHRINE

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation. Read about Epinephrine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
EPIPEN Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
C01CA24	Epinephrine	C Cardiovascular system → C01 Cardiac therapy → C01C Cardiac stimulants excl. cardiac glycosides → C01CA Adrenergic and dopaminergic agents
Discover more medicines within C01CA24

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 8697R, 8698T
Country: CA	Health Products and Food Branch	Identifier(s): 00509558, 00578657
Country: EE	Ravimiamet	Identifier(s): 1124930, 1124941, 1529658, 1529669, 1531033, 1588844, 1588855, 1588866, 1588877
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 178945, 182343, 556156, 564373
Country: FR	Base de données publique des médicaments	Identifier(s): 61846627, 68293517
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 46867, 47195, 91650, 91652
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-299251328, HR-H-987056369
Country: IE	Health Products Regulatory Authority	Identifier(s): 15920, 15928, 15943, 15951
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1322, 1323, 7547, 7653
Country: JP	医薬品医療機器総合機構	Identifier(s): 2451402G2020, 2451402G3026
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1066890, 1066891, 1071715, 1071716
Country: MT	Medicines Authority	Identifier(s): AA770/02603, AA770/02604
Country: NL	Z-Index G-Standaard	Identifier(s): 13780190, 13780212
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 145262, 145289
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 7681, 7682
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100162478, 100261192
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68719001, W68719002, W68720001, W68720002
Country: SG	Health Sciences Authority	Identifier(s): 13288P, 13290P
Country: US	FDA, National Drug Code	Identifier(s): 49502-500, 49502-501
Country: ZA	Health Products Regulatory Authority	Identifier(s): 27/5.1/0063, 38/5.1/0278